HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

AI Algorithm Combines CT Images with Non-Imaging Data to Accurately Predict COVID-19 Patient Outcomes

By HospiMedica International staff writers
Posted on 24 Nov 2020
Illustration
Illustration
A team of engineers at the Rensselaer Polytechnic Institute (Troy, NY, USA) has demonstrated how a new algorithm they developed was able to successfully predict whether or not a COVID-19 patient would need ICU intervention.

With communities across the nation experiencing a wave of COVID-19 infections, clinicians need effective tools that will enable them to aggressively and accurately treat each patient based on their specific disease presentation, health history, and medical risks. The artificial intelligence-based approach could be a valuable tool in determining a proper course of treatment for individual patients.

The research team developed this method by combining chest computed tomography (CT) images that assess the severity of a patient’s lung infection with non-imaging data, such as demographic information, vital signs, and laboratory blood test results. By combining these data points, the algorithm is able to predict patient outcomes, specifically whether or not a patient will need ICU intervention. The algorithm was tested on datasets collected from a total of 295 patients from three different hospitals - one in the US, one in Iran, and one in Italy. Researchers were able to compare the algorithm’s predictions to what kind of treatment a patient actually ended up needing. The researchers will now integrate their new algorithm with another developed previously to assess a patient’s risk of cardiovascular disease using chest CT scans.

“We know that a key factor in COVID mortality is whether a patient has underlying conditions and heart disease is a significant comorbidity,” said Pingkun Yan, an assistant professor of biomedical engineering at Rensselaer Polytechnic Institute who led the research team. “How much this contributes to their disease progress is, right now, fairly subjective. So, we have to have a quantification of their heart condition and then determine how we factor that into this prediction.”

Related Links:
Rensselaer Polytechnic Institute

Gold Member
CPAP Ventilator
Somnus DM18
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Electric Bed
DIXION Intensive Care Bed

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more